Image result for buy sell


Ezion Holdings

Fortified balance sheet

Maintain BUY on Ezion; TP adjusted to S$0.56, following earnings revisions, still based on 0.6x FY16 P/BV. We trimmed FY16-17 forecasts by 32-37% after pushing back vessel deliveries and lowering margins. Nonetheless, we believe core earnings are near bottom and comforted by Ezion’s positive OCF and lower gearing which are much needed in this environment. Ezion is among the stronger players with good assets, positive operating cash flow and decent cash balances. Rerating catalysts stem from oil price rebound, earnings recovery with the resumption of service rigs currently under repair/upgrades in 2017, and successful diversification of its customer base to win new charter contracts.


Read More ...


POSITIVE ON LONG-TERM OUTLOOK - Incorporating recent acquisitions Regional investments positive for Singtel Reiterate BUY on lower S$4.27 FV Singtel last week announced that it has completed 1) the acquisition of shares in Intouch Holdings (Intouch) and Bharti Telecom Ltd (BTL) and 2) placement of shares in Singtel to Temasek. As a result of these transactions, we are also updating our assumptions to incorporate 1) ~2.4% share dilution arising from the share placement, 2) assumption that the remaining S$0.86m will be funded in equal proportion through internal cash and short-term debt, and 3) slightly higher share of results from associates and JVs. Over the longer-term, we have identified three key growth drivers of Singtel: 1) investments in regional dominant telecom players, 2) growing presence in the cyber security industry through Trustwave, and 3) footprint in the growing digital marketing space. However, as we incorporate assumptions for the recent acquisitions, and raise our risk free rate assumption from 2.0% to 2.6% (on the back of soaring treasury yields ever since Trump was chosen as U.S. President, our SOTP-based FV decreases from S$4.40 to S$4.27. Reiterate BUY on Singtel.


IHH Healthcare (IHH SP)

9M16: Expect A Flat 2016 On Continued Cost Pressure

IHH’s 9M16 adjusted earnings track below our and consensus forecasts.

While revenue growth remained strong, it was exceeded by staff costs, pre-operating expenses and start-up costs in new hospitals. We lower our 2016-17 net profit estimates by 1-3% to account for higher operating costs. Going forward, we expect cost pressure to continue on the back of expansion plans, helped by the ramp-up of new hospitals opened in 2014 and 2015. Maintain HOLD with a lower SOTP target price of S$2.03 (previously S$2.14). Entry price: S$1.80.


Read More ...




LionelLim8.16Check out our compilation of Target Prices

Share Prices

Counter NameLastChange
AEM Holdings3.8700.030
Avi-Tech Electronics0.2800.005
Best World1.7900.030
Broadway Ind0.118-
China Sunsine0.405-
Food Empire0.635-0.015
Fortress Minerals0.330-
Geo Energy Res0.360-0.015
Golden Energy0.7850.005
GSS Energy0.0480.002
ISDN Holdings0.4150.010
IX Biopharma0.1270.001
Jiutian Chemical0.0820.004
KSH Holdings0.350-
Leader Env0.056-
Medtecs Intl0.139-0.001
Meta Health0.025-
Nordic Group0.475-0.005
Oxley Holdings0.1500.001
REX International0.2400.005
Sinostar PEC0.1850.015
Southern Alliance Mining0.380-
Straco Corp.0.400-0.005
Sunpower Group0.2850.025
The Trendlines0.0930.005
Totm Technologies0.103-0.002
UG Healthcare0.194-0.001
Uni-Asia Group0.8350.005
Wilmar Intl4.120-
Yangzijiang Shipbldg1.410-0.010

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 810 guests and no members online